Danaher Corporation (NYSE:DHR) CFO Daniel L. Comas sold 88,184 shares of Danaher Corporation stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $91.02, for a total transaction of $8,026,507.68. Following the completion of the transaction, the chief financial officer now owns 227,816 shares of the company’s stock, valued at $20,735,812.32. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Shares of Danaher Corporation (NYSE:DHR) traded down $0.74 during trading on Friday, hitting $92.24. 2,361,600 shares of the stock were exchanged, compared to its average volume of 2,688,302. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. Danaher Corporation has a 52-week low of $76.27 and a 52-week high of $93.36. The stock has a market cap of $64,677.37, a P/E ratio of 23.90, a P/E/G ratio of 2.21 and a beta of 1.02.
Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The firm had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same period in the previous year, the business posted $0.87 EPS. The business’s revenue was up 9.6% compared to the same quarter last year. equities research analysts expect that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were paid a $0.14 dividend. The ex-dividend date was Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.61%. Danaher Corporation’s dividend payout ratio is currently 16.52%.
COPYRIGHT VIOLATION NOTICE: “Danaher Corporation (NYSE:DHR) CFO Daniel L. Comas Sells 88,184 Shares” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2017/11/11/daniel-l-comas-sells-88184-shares-of-danaher-corporation-dhr-stock.html.
Several institutional investors and hedge funds have recently made changes to their positions in the company. GQG Partners LLC acquired a new stake in Danaher Corporation in the second quarter valued at $101,000. Proficio Capital Partners LLC raised its position in shares of Danaher Corporation by 92.3% in the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 598 shares in the last quarter. Monetary Management Group Inc. raised its position in shares of Danaher Corporation by 10.7% in the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after purchasing an additional 150 shares in the last quarter. Acrospire Investment Management LLC raised its position in shares of Danaher Corporation by 185.5% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after purchasing an additional 1,100 shares in the last quarter. Finally, ClariVest Asset Management LLC acquired a new position in shares of Danaher Corporation in the 1st quarter valued at approximately $157,000. Institutional investors and hedge funds own 75.61% of the company’s stock.
A number of equities research analysts have weighed in on DHR shares. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Cowen and Company reiterated a “buy” rating and set a $90.00 price target on shares of Danaher Corporation in a report on Wednesday, October 4th. Jefferies Group LLC restated a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $95.00 price target (up from $86.00) on shares of Danaher Corporation in a research report on Friday, October 6th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $93.31.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.